ID   FbEM-1
AC   CVCL_0Q76
DR   Wikidata; Q54833274
RX   PubMed=9286736;
RX   PubMed=10956554;
RX   PubMed=32106286;
CC   Doubling time: ~38 hours (PubMed=9286736).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
RX   PubMed=9286736; DOI=10.1093/humupd/3.2.117;
RA   Bouquet de la Joliniere J., Validire P., Canis M., Doussau M.,
RA   Levardon M., Gogusev J.;
RT   "Human endometriosis-derived permanent cell line (FbEM-1):
RT   establishment and characterization.";
RL   Hum. Reprod. Update 3:117-123(1997).
//
RX   PubMed=10956554; DOI=10.1093/molehr/6.9.821;
RA   Gogusev J., Bouquet de la Joliniere J., Telvi L., Doussau M.,
RA   du Manoir S., Stojkoski A., Levardon M.;
RT   "Genetic abnormalities detected by comparative genomic hybridization
RT   in a human endometriosis-derived cell line.";
RL   Mol. Hum. Reprod. 6:821-827(2000).
//
RX   PubMed=32106286; DOI=10.1093/humrep/dez266; PMCID=PMC7048714;
RA   Romano A., Xanthoulea S., Giacomini E., Delvoux B., Alleva E.,
RA   Vigano P.;
RT   "Endometriotic cell culture contamination and authenticity: a source
RT   of bias in in vitro research?";
RL   Hum. Reprod. 35:364-376(2020).
//